Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

First line chemotherapy in low risk gestational trophoblastic neoplasia.

Alazzam M, Tidy J, Hancock BW, Osborne R.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007102. doi: 10.1002/14651858.CD007102.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD007102.

PMID:
19160319
2.

First-line chemotherapy in low-risk gestational trophoblastic neoplasia.

Alazzam M, Tidy J, Hancock BW, Osborne R, Lawrie TA.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD007102. doi: 10.1002/14651858.CD007102.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;(6):CD007102.

3.

First-line chemotherapy in low-risk gestational trophoblastic neoplasia.

Lawrie TA, Alazzam M, Tidy J, Hancock BW, Osborne R.

Cochrane Database Syst Rev. 2016 Jun 9;(6):CD007102. doi: 10.1002/14651858.CD007102.pub4. Review.

PMID:
27281496
4.

Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.

Deng L, Zhang J, Wu T, Lawrie TA.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD005196. doi: 10.1002/14651858.CD005196.pub4. Review.

PMID:
23440800
5.

Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.

Fu J, Fang F, Xie L, Chen H, He F, Wu T, Hu L, Lawrie TA.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD007289. doi: 10.1002/14651858.CD007289.pub2. Review.

PMID:
23076934
6.

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.

Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA.

Cochrane Database Syst Rev. 2016 Jan 13;(1):CD008891. doi: 10.1002/14651858.CD008891.pub3. Review.

PMID:
26760424
7.

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.

Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD008891. doi: 10.1002/14651858.CD008891.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;1:CD008891.

PMID:
23235667
8.

Combination chemotherapy for high-risk gestational trophoblastic tumour.

Xue Y, Zhang J, Wu TX, An RF.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005196. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD005196.

PMID:
16856085
9.

Combination chemotherapy for high-risk gestational trophoblastic tumour.

Deng L, Yan X, Zhang J, Wu T.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD005196. doi: 10.1002/14651858.CD005196.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;1:CD005196.

PMID:
19370618
10.

A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia.

Shah NT, Barroilhet L, Berkowitz RS, Goldstein DP, Horowitz N.

J Reprod Med. 2012 May-Jun;57(5-6):211-8.

PMID:
22696815
11.

Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.

Pienaar ED, Young T, Holmes H.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD003940. doi: 10.1002/14651858.CD003940.pub3. Review.

PMID:
21069679
12.

Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?

Miller CR, Chappell NP, Sledge C, Leath CA 3rd, Phippen NT, Havrilesky LJ, Barnett JC.

Gynecol Oncol. 2017 Jan;144(1):125-129. doi: 10.1016/j.ygyno.2016.10.038. Epub 2016 Nov 3.

PMID:
27816248
13.

Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).

Bergner N, Monsef I, Illerhaus G, Engert A, Skoetz N.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD009355. doi: 10.1002/14651858.CD009355.pub2. Review.

PMID:
23152274
14.

Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.

Abrão RA, de Andrade JM, Tiezzi DG, Marana HR, Candido dos Reis FJ, Clagnan WS.

Gynecol Oncol. 2008 Jan;108(1):149-53. Epub 2007 Oct 10.

PMID:
17931696
15.

Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.

Osborne RJ, Filiaci V, Schink JC, Mannel RS, Alvarez Secord A, Kelley JL, Provencher D, Scott Miller D, Covens AL, Lage JM.

J Clin Oncol. 2011 Mar 1;29(7):825-31. doi: 10.1200/JCO.2010.30.4386. Epub 2011 Jan 24.

16.

Medical methods for first trimester abortion.

Kulier R, Kapp N, Gülmezoglu AM, Hofmeyr GJ, Cheng L, Campana A.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD002855. doi: 10.1002/14651858.CD002855.pub4. Review.

PMID:
22071804
17.

Combined methotrexate-dactinomycin: an effective therapy for low-risk gestational trophoblastic neoplasia.

Eiriksson L, Wells T, Steed H, Schepansky A, Capstick V, Hoskins P, Pike J, Swenerton K.

Gynecol Oncol. 2012 Mar;124(3):553-7. doi: 10.1016/j.ygyno.2011.10.036. Epub 2011 Nov 9.

PMID:
22079360
18.

Medical methods for first trimester abortion.

Kulier R, Gülmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A.

Cochrane Database Syst Rev. 2004;(2):CD002855. Review. Update in: Cochrane Database Syst Rev. 2011;(11):CD002855.

PMID:
15106180
19.

Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.

Kang WD, Choi HS, Kim SM.

Gynecol Oncol. 2010 Jun;117(3):477-80. doi: 10.1016/j.ygyno.2010.02.029. Epub 2010 Mar 29.

PMID:
20347479
20.

Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.

Shelley M, Cleves A, Wilt TJ, Mason M.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD008976. doi: 10.1002/14651858.CD008976.pub2. Review.

PMID:
21491413

Supplemental Content

Support Center